In the last few years the number of clinical trials looking for new treatments for Leukemia (AML) has continued to grow. In 2017, a report from ManagedCare said that: “… There are over 400 phase 2 or phase 3 trials currently recruiting or underway for the...
Pivotal Study to Evaluate Potential of Anti-CD3 Monoclonal Antibody to Intercept Type 1 Diabetes Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that it...
NanOlogy may offer an alternative treatment option for patients with bladder cancer Investigational drug, NanoDoce, is injected locally into tumor resection bed via cystoscope guidance followed by intravesical instillation NanOlogy, a clinical-stage oncology company,...
Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B and age-related diseases, today announced that it has entered into a strategic collaboration with Shanghai Junshi Biosciences Co.,...
MERLIN is one of four separate clinical trials studying ORBCEL stromal cell immunotherapies designed to treat some of the most challenging diseases Orbsen Therapeutics, a biotechnology company focused on the development and commercialization of first-in-class stromal...
Email
Text